- Home
- PTN vs XAIR Comparison
PTN vs XAIR Comparison
Compare PTN & XAIR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PTN
- XAIR
- Stock Information
- Founded
- PTN 1986
- XAIR 2011
- Country
- PTN United States
- XAIR United States
- Employees
- PTN N/A
- XAIR N/A
- Industry
- PTN Biotechnology: Pharmaceutical Preparations
- XAIR Medical/Dental Instruments
- Sector
- PTN Health Care
- XAIR Health Care
- Exchange
- PTN Nasdaq
- XAIR Nasdaq
- Market Cap
- PTN 25.4M
- XAIR 26.0M
- IPO Year
- PTN 1993
- XAIR N/A
- Fundamental
- Price
- PTN $1.06
- XAIR $0.42
- Analyst Decision
- PTN Strong Buy
- XAIR Strong Buy
- Analyst Count
- PTN 1
- XAIR 4
- Target Price
- PTN $17.00
- XAIR $3.67
- AVG Volume (30 Days)
- PTN 570.9K
- XAIR 2.3M
- Earning Date
- PTN 02-13-2025
- XAIR 02-10-2025
- Dividend Yield
- PTN N/A
- XAIR N/A
- EPS Growth
- PTN N/A
- XAIR N/A
- EPS
- PTN N/A
- XAIR N/A
- Revenue
- PTN $2,384,113.00
- XAIR $2,342,000.00
- Revenue This Year
- PTN N/A
- XAIR $230.80
- Revenue Next Year
- PTN N/A
- XAIR $265.55
- P/E Ratio
- PTN N/A
- XAIR N/A
- Revenue Growth
- PTN N/A
- XAIR 685.91
- 52 Week Low
- PTN $0.68
- XAIR $0.30
- 52 Week High
- PTN $5.65
- XAIR $2.17
- Technical
- Relative Strength Index (RSI)
- PTN 47.60
- XAIR 51.29
- Support Level
- PTN $1.06
- XAIR $0.34
- Resistance Level
- PTN $1.20
- XAIR $0.38
- Average True Range (ATR)
- PTN 0.14
- XAIR 0.06
- MACD
- PTN -0.01
- XAIR 0.00
- Stochastic Oscillator
- PTN 7.14
- XAIR 40.62
About PTN Palatin Technologies Inc.
Palatin Technologies Inc is a biopharmaceutical company developing first-in-class medicines based on molecules that modulate the activity of the melanocortin receptor system. The product candidates are targeted, receptor-specific therapeutics for the treatment of diseases with significant unmet medical need and commercial potential.
About XAIR Beyond Air Inc.
Beyond Air Inc is a commercial-stage medical device and biopharmaceutical company that develops a Nitric Oxide (NO) Generator and Delivery System that uses NO generated from ambient air and delivers precise amounts of NO to the lungs for the potential treatment of respiratory and other diseases. The firm is applying its therapeutic expertise to develop treatments for pulmonary hypertension, in addition to treatments for lower respiratory tract infections.